RxSight, Inc. (RXST)

SEC filing

RxSight, Inc.

RXST · CIK 1111485

4 · Sep 2, 2026 · Chief Financial Officer Wilterding Mark sold 7,765 shares at $6.96/share ($54,044); exercised options for 40.88K shares

Chief Financial Officer Wilterding Mark sold 7,765 shares at $6.96/share ($54,044); exercised options for 40.88K shares

Could not load the primary document from EDGAR (temporary SEC rate limit or timeout). Refresh in a few seconds, or use View on SEC.gov.